Patents Assigned to Genta Inc.
  • Antisense oligonucleotides which reduce expression of the FGFRI gene
    Patent number: 5783683
    Abstract: Antisense molecules, compositions thereof, and vectors encoding antisense RNA, and methods of using antisense molecules, compositions, and vectors for treating human glioblastoma cells in order to suppress the growth of the cells. The antisense molecules are substantially complementary to human fibroblast growth factor receptor gene one (the FGFR1).
    Type: Grant
    Filed: January 10, 1995
    Date of Patent: July 21, 1998
    Assignee: Genta Inc.
    Inventor: Richard S. Morrison